CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

ASX 200 Market Outlook: Healthcare Rebound Mixed for CSL, PME, SHL

By :   Matt Simpson , Market Analyst

The ASX 200 found some footing on Tuesday after Monday’s shaky start, but conviction remains low with the index still trading under its 200-day average. Sector breadth was mixed and volatility stayed compressed, hinting at indecision ahead of the key December period. Healthcare led the improvement last week, yet its rebound remains patchy, with CSL, PME and SHL moving in different directions. With seasonality set to become more supportive from mid-December, traders will be watching whether this week brings follow-through or a renewed slip in momentum.

 

View related analysis:

 

Healthcare Rebound Remains Mixed

ASX 200 Market Snapshot

  • The Australian share market stabilised on Tuesday after a shaky start to the month.
  • A bullish inside day and a potential inverted hammer formed, although the ASX 200 cash index remains below its 200-day SMA (5891.8).
  • The narrow trading range — the smallest in 11 weeks — also highlights a lack of conviction from both sides.
  • Near-term risks still tilt lower following last week’s swing high, but as discussed in Tuesday’s report, the seasonal case for a Santa rally strengthens from mid-December.
  • Six of eleven ASX sectors finished lower, led by Information Technology (XIJ) and Utilities (XUJ). Energy (XEJ) and Materials (XMJ) outperformed on the day.
  • Financials (XFJ) saw selling pressure ease, and CBA continues to hold above 150 and its 20-month EMA — a key level for broader ASX sentiment.

Chart analysis by Matt Simpson - source: ASX, LSEG

 

 

ASX 200 Correlations

  • The 10-day correlation between the financials index and the broader market is effectively zero at -0.11, suggesting the 150 level on CBA may not carry the same weight it once did.
  • Materials remain well-aligned with the index over the 10-day lookback at 0.73.
  • Broader risk correlations stay firm, with the ASX 200 tracking closely with the DAX (0.93), Nikkei (0.91) and S&P 500 (0.87).

Chart analysis by Matt Simpson - source: ASX, LSEG

 

ASX 200 Healthcare (XHJ) Rebound Could be Limited

The healthcare sector (XHJ) posted its best week in eight after finding support above the 2023 low. Near-term oversold conditions helped, but the broader bearish backdrop remains. XHJ has now retraced around half of last week’s bullish engulfing candle, so the next few sessions will show whether buyers can build on this. Seasonality could lend support in the second half of December, but the sector may struggle unless key constituents start to turn higher.

ASX 200 Healthcare sector (XHJ) chart with CSL, Pro Medicus (PME) and Sonic Healthcare (SHL) technical analysis showing bearish trends, key EMAs, swing-high signals and potential SHL breakout – source: TradingView.

Chart analysis by Matt Simpson - source: ASX, LSEG

 

 

CSL Retains a Bearish Bias

CSL, the sector heavyweight, remains structurally bearish. The recovery from the October low still looks corrective, with price capped below the September low and the 50-day EMA. Bears will be watching for momentum to roll over towards the 160 target, near the November 2018 low (158.43). A break above 190 would imply a deeper retracement, but the downside target stays intact unless the broader trend changes.

Pro Medicus (PME) Hints at Swing High

PME remains in a downtrend, and Monday produced a bearish engulfing candle around the 50-day and 200-day EMAs — a pattern that often precedes a swing high.

Sonic Healthcare (SHL)

SHL is the only major healthcare name showing early signs of potential outperformance. After a multi-week consolidation, price broke above $22 before forming a bull flag. Momentum extended on Tuesday, hinting at a breakout. Bulls will want to see a clean move above the April low (23.76) and the 200-day EMA (~24) to confirm the trend shift.

 

 

View the full economic calendar

 

-- Written by Matt Simpson

Follow Matt on Twitter @cLeverEdge

 

 

 

The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Products and services available depend on your location and the entity holding your account. Before deciding to trade forex, commodity futures, or digital assets, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to FOREX.com or GAIN Capital refer to StoneX Group Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

FOREX.com is a registered FCM and RFED with the CFTC and member of the National Futures Association (NFA # 0339826). Forex trading involves significant risk of loss and is not suitable for all investors. Full Disclosures and Risk Warning. Increased leverage increases risk.

GAIN Capital Group LLC (dba FOREX.com) 30 Independence Blvd, Suite 300 (3rd floor), Warren, NJ 07059, USA. GAIN Capital Group LLC is a wholly-owned subsidiary of StoneX Group Inc.

© FOREX.COM 2026